Susan Hasty, Publisher
Table of Contents . . . February 8th, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Law Weekly | Other Publications
Abbott Laboratories - Indiana Circuit Court denies class certification in OxyContin litigation
Beckman Coulter, Inc. - Exclusive license agreement signed for intellectual property
BioVeris Corporation - Agreements completed with Children's Hospital & Research Center at Oakland
Biophan Technologies, Inc. - Biomedical technology firm executes letter of intent to acquire MRI company
Biophan Technologies, Inc. - Company's biomedical intellectual property portfolio crosses 100-patent mark
Bruckner Group - Biotechnology drug revenues will be hard hit by strict benefit management
CorePharma, LLC - CollaGenex seeks immediate injunctive relief to enforce its patent
Drug Importation - Canadian drug import law goes into effect
Healthcare Coverage - Employers keeping retiree drug coverage even after Part D becomes available
Legal Issues - Illinois investigating prescription drug company, report says
MedPanel, Inc. - Medical market intelligence provider launches financial group
Non-Prescription Drugs - Methamphetamine bill sparks concerns for pharmacies, others
Pharmaceutical Research and Manufact. of America - Drug discount program launched in Ohio
Powell Goldstein LLP - Law firm adds partner specializing in intellectual property and biotechnology
Sanofi-aventis - Vaccine division changes its name
Abbott - NDA submitted to U.S. FDA for advanced prostate cancer drug
Abbott Laboratories - Potent disubstituted pyridazinone cyclooxgenase-2 inhibitor developed
Aegera Therapeutics, Inc. - New board members appointed at biotech firm
Altana AG - Alvesco launched in U.K.
Amarin Corporation plc - Positive data reported from phase IIa studies of Miraxion
Arena Pharmaceuticals, Inc. - Phase II study initiated for anti-obesity compound
Argenta Discovery Ltd - Drug discovery firm appoints Ian Kent as chairman
AtheroGenics, Inc. - Pharmaceutical firm prices private offering of convertible notes
Bausch & Lomb - Ophthalmology firm to license Plasmin from Bayer
Becton, Dickinson and Company - FDA clearance granted for MRSA test
BioSante Pharmaceuticals, Inc. - Enrollment completed for Phase III clinical trial for estrogen gel
BioTec-Grunderzentrum, Braunschweig - Macrophage-activating lipopeptide accelerates wound healing in diabetes
Biovail Corporation - Approvable letter granted for Tramadol ODT
Bolder BioTechnology, Inc. - U.S. NIH grant to fund development of erythropoiesis-stimulating protein
Boston University - Leptin may be involved in placental establishment in early pregnancy
Boston University - Telomere homolog oligonucleotides induce senescence in malignant fibroblasts
BrainStorm Cell Therapeutics, Inc. - Dudy Stolick named chief financial officer at biotech firm
Brigham and Women's Hospital, Boston - Obesity and weight gain increase risk for kidney stones
CHF Solutions, Inc. - $22.9M financing completed; proceeds used to complete UNLOAD trial
CHU Timone, Marseille - IV immunoglobulin used to treat HIV patient with DILS-associated myositis
CONICET, La Plata - Report provides a chart of 25 diseases and 42 plant species employed in therapy
CRC Health Group - Thomas J. Brady named chief medical officer for substance abuse facility
Cambrex Bio Science Walkersville, Inc. - Geron agrees to distribution deal for telomerase-immortalized human cell lines
CeMines, Inc. - VTAK, a new company, to focus on diagnostic and therapeutic cancer products
Center Jean Perrin, Clermont Ferrand 1 - Researchers report on molecular mechanisms in hormonorefractory prostate cancer
Centre National de la Recherche Scientifique - Self-reactive T cell receptor-reactive CD8+ T cells inhibit lymphoma growth
Children's Hospital of Philadelphia - Heparin studied, dichotomy in anticoagulant and antithrombotic effects revealed
Chinese Academy of Sciences - Capillary electrophoresis assay devised for analysis of Rhodiola compounds
Cook, Inc. - First fenestrated endograft in study of advanced treatment for AAA is implanted
Cubist Pharmaceuticals, Inc. - Company reports Q4 Cubicin revenues of $21.0M, year-end net revenue of $58.6M
Curis, Inc. - BMP-7 promotes regeneration of injured kidneys in preclinical model
CytRx Corp. - Data shows potential of arimoclomol as a therapeutic for type 2 diabetes
Decision Resources, Inc. - Advisory firm finds doctors are at odd over fixed-dose statin combinations
Devi Ahilya University - Hypoglycemia from plant extract mediated by corticosteroid inhibition
Diet & Nutrition - Congressman asks lawmakers to focus more on preventative health
Drug Addiction - Methamphetamine-related treatment admissions increase in metro area
Duke University - Small interfering RNA augments hypoxia and radiation induced tumor cell death
Duke University, Durham - Trimetrexate/denileukin diftitox depletes T cells from PBMC/UCB grafts
Duska Therapeutics, Inc. - Pennsylvania biotech announces Standard & Poor's listing
Dyax Corp. - Antibodies enter clinical trials at ImClone Systems
Edward Jenner Institute Vaccine Res. Berkshire - Kinetics and clonality of immunological memory in humans reviewed
Egg Nutrition Center - What's on your plate may help save your sight, research shows
Emory University - Antigen-independent T cells do not develop during chronic viral infection
Emory University - Generation and maintenance of immunological memory reviewed
Emory University, Atlanta - Influence of antipsychotic drugs studied, role of receptor antagonist revealed
Emory Vaccine Center - Anthrax lethal toxin causes multisystem destruction
Enzo Biochem, Inc. - Company wins $1M grant to fund clinical trial of liver disease treatment
ID Biomedical Corporation - Biotechnology company receives U.S. FDA clearance for Fluviral clinical testing
Medical Misconduct - Prosecutor alleges Arizona hospital hid evidence of alleged rapes
Ranbaxy Inc. - Pharma company files three antiretrovirals with the U.S. FDA
Raven biotechnologies, inc. - Biotech company begins enrollment of phase 1/2a trial of RAV12
Samaritan Pharmaceuticals, Inc. - Pharmaceutical company prepares for late-stage clinical trials for HIV treatment
Sepracor Inc. - Commercial availability date for eszopiclone treatment for insomnia revised
Skinvisible, Inc. - Hand sanitizer donated to help victims of the tsunami
Spectrum Pharmaceuticals, Inc. - U.S. FDA acceptance for review of ANDA for migraine headache injection announced
U.S. Food & Drug Administration - Genistein and nonylphenol increase hypothalamus volume in male rats
US Oncology, Inc. - U.S. FDA approves albumin-bound nanoparticle paclitaxel for breast cancer
Univ. of Texas SW Medical Center - Recent findings in breast implants described
deCODE genetics - Company awarded $24 million to study genetics of infectious disease and vaccines
diaDexus, Inc. - Study supports novel test measure as risk predictor of coronary events, strokes
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.